Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma-Reference-Cited by-同舟云学术

Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma

Published:2014-09-16 Issue:1 Volume:15 Page:
ISSN:1465-993X
Container-title:Respiratory Research
language:en
Short-container-title:Respir Res

Author:

El Mays Tamer Y,Choudhury Parichita,Leigh Richard,Koumoundouros Emmanuel,Van der Velden Joanne,Shrestha Grishma,Pieron Cora A,Dennis John H,Green Francis HY,Snibson Ken J

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1186/s12931-014-0098-x/fulltext.html

Reference63 articles.

1. Hamid Q: Pathogenesis of small airways in asthma. Respiration. 2012, 84: 4-11. 10.1159/000339550.

2. Sugita M, Kuribayashi K, Nakagomi T, Miyata S, Matsuyama T, Kitada O: Allergic bronchial asthma: airway inflammation and hyperresponsiveness. Intern Med. 2003, 42: 636-643. 10.2169/internalmedicine.42.636.

3. Kelly MM, O’Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O’Byrne PM: Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol. 2010, 125: 349-356. 10.1016/j.jaci.2009.09.011.

4. Boser SR, Park H, Perry SF, Menache MG, Green FH: Fractal geometry of airway remodeling in human asthma. Am J Respir Crit Care Med. 2005, 172: 817-823. 10.1164/rccm.200411-1463OC.

5. Gotshall RW: Exercise-induced bronchoconstriction. Drugs. 2002, 62: 1725-1739. 10.2165/00003495-200262120-00003.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing airway smooth muscle tone: a comprehensive review with a special emphasis on pulmonary surfactant;American Journal of Physiology-Cell Physiology;2024-09-01

2. Hypercapnia and its relationship with respiratory infections;Expert Review of Respiratory Medicine;2024-02

3. Carbon dioxide and MAPK signalling: towards therapy for inflammation;Cell Communication and Signaling;2023-10-10

4. Expert guidance on the management and challenges of long-COVID syndrome: a systematic review;Expert Opinion on Pharmacotherapy;2023-01-01

5. A Phase IIa Open Label Study to Evaluate the Safety, Tolerability and Efficacy of S-1226 Administered by Nebulization in Subjects with Cystic Fibrosis Lung Disease;2021-12-13